A pilot, open-label, multi-centre study to investigate the safety of Calf Intestinal Alkaline Phosphatase in patients with fulminant active ulcerative colitis refractory to steroid therapy.
Phase of Trial: Phase I
Latest Information Update: 09 Sep 2011
At a glance
- Drugs Alkaline phosphatase (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions
- 09 Sep 2011 New source identified and integrated (ISRCTN: Current Controlled Trials).
- 05 Feb 2010 New trial record